Figure 1.
Prognostic impact of MRD levels at end of consolidation I (w+16), as shown by Kaplan-Meier estimates of OS, DFS, and RD. (A) OS, DFS, and RD in the total cohort of patients stratified by RQ-PCR as MolCR (MRD negativity with assays sensitivity of at least 10−4), MolFail (MRD positivity with a level of at least 10−4), and patients not fitting into these categories (MolNE). (B) OS, DFS, and RD according to NGS-MRD in patients who were MolNE by RQ-PCR. x-axis, years; y-axis, survival probability.

Prognostic impact of MRD levels at end of consolidation I (w+16), as shown by Kaplan-Meier estimates of OS, DFS, and RD. (A) OS, DFS, and RD in the total cohort of patients stratified by RQ-PCR as MolCR (MRD negativity with assays sensitivity of at least 10−4), MolFail (MRD positivity with a level of at least 10−4), and patients not fitting into these categories (MolNE). (B) OS, DFS, and RD according to NGS-MRD in patients who were MolNE by RQ-PCR. x-axis, years; y-axis, survival probability.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal